Showing results (141-150 of 914) with videos related to
Sort By:
Pageof 92
Annals of Neurology|January 1, 1992
Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research GroupD T Dexter, P Jenner, A H Schapira, et al.Biochemical Pharmacology|May 11, 1995
Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviourK K Gnanalingham, A J Hunter, P Jenner, et al.Psychopharmacology|February 1, 1995
The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's diseaseK K Gnanalingham, A J Hunter, P Jenner, et al.The Journal of Pharmacy and Pharmacology|March 1, 1983
Hypophysectomy does not prevent increased cerebral dopamine turnover following sulpiride administrationL M Reynolds, R G Dyer, P Jenner, et al.Synapse (New York, N.Y.)|July 1, 1997
Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmosetG M Mackenzie, M J Jackson, P Jenner, et al.Neuroscience|January 1, 1984
A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slicesR W Kerwin, N M Rupniak, P Jenner, et al.European Journal of Pharmacology|October 1, 1976
The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleusI Donaldson, A Dolphin, P Jenner, et al.Neuroscience Letters|August 23, 1996
D3 receptor expression within the basal ganglia is not affected by Parkinson's diseaseM J Hurley, C M Stubbs, P Jenner, et al.Psychopharmacology|February 1, 1995
Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primateK K Gnanalingham, A J Hunter, P Jenner, et al.Neuroscience Letters|October 1, 1993
Parallel alterations in Met-enkephalin and substance P levels in medial globus pallidus in Parkinson's disease patientsM L de Ceballos, A Fernandez, P Jenner, et al.Pageof 92